Description

You will provide medical and scientific leadership for Natera-sponsored oncology clinical trials focused on minimal residual disease (MRD), driving the design and execution of biomarker-driven studies that integrate MRD testing into precision oncology strategies to support regulatory, scientific, and strategic objectives.

Requirements

• Medical degree (MD)
• Deep oncology clinical development experience
• Experience with biomarker-driven interventional and randomized studies
• Knowledge of GCP and regulatory requirements for clinical trials
• Ability to collaborate with investigators, KOLs, and regulatory authorities

Responsibilities

• Serve as program-level medical lead for MRD clinical trials, accountable for clinical outcomes, data integrity, and patient safety
• Define clinical development strategies aligning study design with regulatory and scientific objectives
• Provide medical oversight across full trial lifecycle from design through close-out
• Act as Medical Monitor for safety signal detection and risk mitigation
• Partner cross-functionally with Clinical Science, Operations, Data Management, and Biostatistics